What are the DSM-5 (Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition) criteria for Attention Deficit Hyperactivity Disorder (ADHD)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The DSM-5 criteria for ADHD require a persistent pattern of inattention and/or hyperactivity-impulsivity that interferes with functioning or development, with at least 5 symptoms for adults and 6 symptoms for children under 17, present for at least 6 months, as outlined in the most recent study 1.

Key Criteria

The criteria for ADHD include:

  • An ongoing pattern of inattentive and/or hyperactive-impulsive symptoms for at least 6 months
  • Multiple inattentive and/or hyperactive-impulsive symptoms, with 5 or more symptoms required for adults and 6 or more for children under 17
  • Symptoms must have an onset before the age of 12
  • Symptoms must be present in 2 or more settings, such as home, work, or school
  • Evidence that symptoms interfere with or reduce the quality of functioning, such as interpersonal or occupational functioning

Inattention Symptoms

Inattention symptoms include:

  • Poor attention to detail
  • Difficulty concentrating or sustaining attention on tasks
  • Difficulty organizing tasks
  • Avoiding tasks requiring sustained mental effort
  • Losing necessary items
  • Being easily distracted
  • Forgetfulness

Hyperactivity-Impulsivity Symptoms

Hyperactivity-impulsivity symptoms include:

  • Fidgeting
  • Leaving seat inappropriately
  • Running or climbing excessively (or restlessness in adults)
  • Difficulty engaging in leisure activities quietly
  • Being "on the go"
  • Talking excessively
  • Blurting out answers
  • Difficulty waiting turn
  • Interrupting others

Diagnosis and Specification

ADHD is specified as predominantly inattentive, predominantly hyperactive-impulsive, or combined presentation, with severity rated as mild, moderate, or severe based on symptom count and functional impairment, as noted in the study 1.

Clinical Evaluation

The clinical evaluation for ADHD should include a comprehensive assessment of symptoms and impairment in multiple settings, as well as ruling out alternative causes, as recommended in the study 1 and 1.

From the Research

DSM-5 Criteria for ADHD

The DSM-5 criteria for Attention Deficit Hyperactivity Disorder (ADHD) require the presence of fewer symptoms to make a diagnosis of adult ADHD, while the criteria for diagnosis in childhood are unchanged compared to previous editions 2.

Key Changes in DSM-5

  • The new DSM-5 requires the presence of fewer current symptoms for a diagnosis of ADHD, with a significant increase (65%) in the number of participants meeting the new cutoff as compared to the old DSM-IV symptoms cutoff 2.
  • The DSM-5 added 4 new symptoms to the hyperactivity and impulsivity aspect, which supports the loading of two factors including inattentiveness and hyperactivity/impulsivity 3.

Diagnostic Criteria

  • The diagnostic criteria for ADHD specify two dimensions of inattention and hyperactivity-impulsivity symptoms that are used to define three nominal subtypes: predominantly hyperactive-impulsive type (ADHD-H), predominantly inattentive type (ADHD-I), and combined type (ADHD-C) 4.
  • The DSM-IV criteria identify individuals with significant and persistent impairment in social, academic, occupational, and adaptive functioning when intelligence, demographic factors, and concurrent psychopathology are controlled 4.

Symptoms and Subtypes

  • The distinction between inattention and hyperactivity-impulsivity symptoms has concurrent, predictive, and discriminant validity 4.
  • The DSM-IV subtype model is compromised by weak evidence for the validity of ADHD-H after first grade, minimal support for the distinction between ADHD-I and ADHD-C in studies of etiological influences, academic and cognitive functioning, and treatment response 4.
  • Empirical support is stronger for an alternative model that would replace the subtypes with dimensional modifiers that reflect the number of inattention and hyperactivity-impulsivity symptoms at the time of assessment 4.

Prevalence and Co-morbidity

  • The prevalence of ADHD is approximately 5% in the general population 5.
  • There is a high co-morbidity of epilepsy and attentional and behavioural problems, including ADHD, with at least 20% of patients with epilepsy presenting with features of ADHD 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

New DSM-5 criteria for ADHD - Does it matter?

Comprehensive psychiatry, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.